Physician

Bisher Mustafa, M.D.

According to 2025 Medicare claims, Bisher Mustafa, M.D. (NPI: 1205361292) practices internal medicine in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Cabell, WV. This provider's primary affiliated billing organization is UNIVERSITY PHYSICIANS & SURGEONS, INC (NPI: 1730183286; TIN: 550564945) and primary practice location at 25705-0001. Mustafa is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Mustafa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 399 traditional Medicare patients, billed 1,993 HCPCS/CPT codes, and received $133,281 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,961 prescription claims across 331 beneficiaries totaling $742,727 in drug costs, led by Ozempic (Semaglutide). DME data shows 14 claims. Open Payments data shows 9 records totaling $189. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $14,009 and ending at $133,281. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,314 to $742,727. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $16,270 to $4,795.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	106	422	$14,009
2018	537	1,325	$78,589
2019	518	1,208	$71,668
2020	418	1,192	$77,898
2021	314	916	$53,577
2022	332	897	$50,860
2023	363	1,248	$74,988
2024	399	1,993	$133,281

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	12	21	$2,314
2018	91	508	$68,453
2019	117	877	$141,208
2020	144	1,166	$241,227
2021	209	1,703	$416,627
2022	297	2,244	$689,554
2023	331	2,826	$951,200
2024	331	2,961	$742,727

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	52	$14,074
2019	N/R	61	$13,779
2020	N/R	53	$11,887
2021	N/R	12	$10,504
2022	N/R	88	$14,994
2023	N/R	25	$1,410
2024	N/R	14	$276

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	116	124	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	95	$66
99238	Hospital discharge day management, 30 minutes or less	100	102	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	233	1,426	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	82	118	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	164	8,096	$266,759
Mounjaro	Tirzepatide	165	5,786	$213,365
Eliquis	Apixaban	45	3,247	$60,095
Jardiance	Empagliflozin	15	1,230	$24,109
Wegovy	Semaglutide	16	448	$21,096

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0001	Standard wheelchair	Y	N/R	14	$276

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$189	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bisher Mustafa, M.D.?

Tedicare shows public-source Medicare data for Bisher Mustafa, M.D. (NPI 1205361292), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bisher Mustafa, M.D. have ACO affiliation data?

Bisher Mustafa, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Bisher Mustafa, M.D.?

Bisher Mustafa, M.D. is linked to UNIVERSITY PHYSICIANS & SURGEONS, INC (billing NPI 1730183286) in the available physician profile data.

Does Bisher Mustafa, M.D. have Open Payments data?

Bisher Mustafa, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.